missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MAVS Antibody - BSA Free, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NBP1-76768-0.025mg
This item is not returnable.
View return policy
Description
MAVS Polyclonal specifically detects MAVS in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.
Specifications
| MAVS | |
| Polyclonal | |
| Unconjugated | |
| PBS with 0.02% Sodium Azide | |
| CARD adapter inducing interferon beta, CARD adapter inducing interferon-beta, CARD adaptor inducing IFN-beta, CARDIF, DKFZp547C224, DKFZp666M015, FLJ27482, IFN-B promoter stimulator 1, Interferon beta promoter stimulator protein 1, interferon-beta promoter stimulator protein 1, IPS-1FLJ41962, IPS1MGC3260, KIAA1271FLJ35386, mitochondrial antiviral signaling protein, mitochondrial antiviral-signaling protein, mitochondrial viral signaling protein, Putative NF-kappa-B-activating protein 031N, virus-induced signaling adapter variant 1b, virus-induced signaling adaptor variant 1a, Virus-induced-signaling adapter, VISAFLJ38051 | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Human | |
| IgG |
| Western Blot | |
| 1 mg/mL | |
| Western Blot 0.5-2 μg/mL, ELISA 1:100-1:2000, Immunohistochemistry 2.5 μg/mL, Immunocytochemistry/Immunofluorescence 20 μg/mL, Immunohistochemistry-Paraffin 2.5 μg/mL | |
| Q7Z434 | |
| MAVS | |
| Antibody was raised against a 17 amino acid synthetic peptide from near the center of human VISA. The immunogen is located within amino acids 130 - 180 of VISA. Amino Acid Squence: MPVQETQAPESPGENSE | |
| 0.025 mg | |
| Immune System Diseases, Immunology, Protein Kinase | |
| 57506 | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction